MoneyWorks4Me

Shilpa Medicare - Quaterly Results

29 Oct 2021 Evaluate
A fair growth of 8.83% in the revenue at Rs. 2858.71 millions was reported in the September 2021 quarter as compared to Rs. 2626.78 millions during year-ago period.The Net proft of the company remain more or less same to Rs. 436.22  millions from Rs. 547.78 millions ,decline by -20.37%.Operating profit for the quarter ended September 2021 decreased to 730.41 millions as compared to 889.03 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 2858.71 2626.78 8.83 5261.98 4793.14 9.78 8303.16 8059.71 3.02
Other Income 91.06 75.21 21.07 188.97 101.56 86.07 339.00 112.63 200.99
PBIDT 730.41 889.03 -17.84 1231.75 1691.23 -27.17 2609.07 2561.68 1.85
Interest 78.48 33.40 134.97 148.37 68.80 115.65 174.68 43.29 303.51
PBDT 741.02 855.63 -13.39 1172.47 2151.92 -45.52 2963.87 2472.97 19.85
Depreciation 131.25 98.39 33.40 248.11 197.49 25.63 408.48 349.57 16.85
PBT 609.77 757.24 -19.47 924.36 1954.43 -52.70 2555.39 2123.40 20.34
TAX 173.55 209.46 -17.14 236.67 545.23 -56.59 711.47 441.46 61.16
Deferred Tax 67.01 78.66 -14.81 75.17 205.13 -63.35 264.48 50.52 423.52
PAT 436.22 547.78 -20.37 687.69 1409.20 -51.20 1843.92 1681.94 9.63
Equity 81.53 81.53 0.00 81.53 81.53 0.00 81.53 81.53 0.00
PBIDTM(%) 25.55 33.84 -24.51 23.41 35.28 -33.66 31.42 31.78 -1.14
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..